Awiqli offers eligible adults with type 2 diabetes a once-weekly alternative to daily basal insulin, reducing injections from ...
Starmer’s former deputy has returned to frontline politics as Housing Secretary – despite being sidelined by close allies of ...
LONDON—Alexander Zverev was dealing with more than just defending champion Jannik Sinner on Sunday in the Wimbledon final.
3.5 million people could now be living with an eating disorder according to national charity Beat - with calls for major ...
Alexander Zverev's Grand Slam victory highlights the challenges of managing Type 1 diabetes as a professional athlete.
A midnight-shift employee fired for sleeping on the job mentioned fatigue and dry eye too late to properly invoke the ...
People with diabetes who depend on Tandem Mobi insulin pumps to deliver life-sustaining doses around the clock face a direct ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Embecta Corp. and certain of the Company's senior executives for securities fraud ...
Lucknow: India’s first once-weekly long-acting insulin, Awiqli (insulin icodec) was launched in Lucknow on Saturday and is ...
Sun Pharma has received South African approval for its generic semaglutide injection, expanding access to affordable ...
When sisters Jan and Jill Shropshire traveled to the UK in 1997, they were excited for an adventure. Then they broke the key ...
For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...